The Ohio State University Dermatology Biorepository

RECRUITING

I'm interested ...!!

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Conditions:

🦠 Hidradenitis Suppurativa

🗓️ Study Start (Actual) 19 April 2017

🗓️ Primary Completion (Estimated) 31 December 2030

✅ Study Completion (Estimated) 31 December 2030

👥 Enrollment (Estimated) 175

🔬 Study Type OBSERVATIONAL

📊 Phase N/A

Locations:

📍 Columbus, Ohio, United States

📋 Eligibility Criteria

Description

Inclusion Criteria:

* Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
* Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
* Willingness to participate in a research study.

Exclusion Criteria:

* Inability to provide informed consent

Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted 5 May 2017
First Submitted that Met QC Criteria 9 May 2017
First Posted 10 May 2017

Study Record Updates

Last Update Submitted that Met QC Criteria 2 April 2024
Last Update Posted 3 April 2024
Last Verified April 2024